Baidu
map
CARDIOVASC PATHOL 润色咨询

CARDIOVASCULAR PATHOLOGY

出版年份：1992 年文章数：644 投稿命中率： 开通期刊会员，数据随心看

出版周期：Bimonthly 自引率：3.7% 审稿周期： 开通期刊会员，数据随心看

前往期刊查询
期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索

期刊讨论

  1. [GetPortalCommentsPageByObjectIdResponse(id=926075, encodeId=1cb79260e563, content=审稿速度:2.0 | 投稿命中率:95.0<br>经验分享：去年疫情期间投稿两篇文章，审稿时间回复很快，1-1.5月，一篇按照专家意见反复修改，另一篇小修。应该是心血管病理专业文章，对口强，均已经发表。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=143, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=176b1539528, createdName=病理微人, createdTime=Sun Feb 21 11:32:00 CST 2021, time=2021-02-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=509710, encodeId=74eb509e10cd, content=审稿速度:3.0 | 投稿命中率:50.0<br>经验分享：本人投了一篇综述，中了，有关先天性心脏病分子机制的，在当时比较有创意，小修后就收了。感觉不是很难。后来投了一篇论著，直接被拒了。Huang JB, Liu YL, Sun PW, Lv XD, Du M, Fan XM. Molecular mechanisms of congenital heart disease.Cardiovasc Pathol. 2010 Sep-Oct;19(5):e183-93., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=430, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=85f118338, createdName=b2007117, createdTime=Mon Feb 09 16:42:00 CST 2015, time=2015-02-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=849465, encodeId=8497849465d4, content=相对不错的一个期刊，这几年if慢慢起来了，应该可以吸引到更多好文章吧 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=146, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a87f5414135, createdName=ms9016875260525266, createdTime=Wed Jan 23 17:29:33 CST 2019, time=2019-01-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=539957, encodeId=b4b453995e8a, content=有所上涨，看好未来，大家认为呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=350, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=yang_guoqiang2010, createdTime=Tue Jul 18 18:37:00 CST 2017, time=2017-07-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=491322, encodeId=fa404913227f, content=审稿速度:1.0 | 投稿命中率:25.0<br>经验分享：三篇都是大修，然后都被拒, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=400, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=Dong, createdTime=Fri Nov 02 10:43:00 CST 2012, time=2012-11-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=478307, encodeId=e6664e830766, content=偏重的研究方向：心血管;, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=430, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=null, createdTime=Wed Jun 29 15:29:00 CST 2011, time=2011-06-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=477150, encodeId=a9cd4e71505b, content=偏重的研究方向：心血管;, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=536, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6d5828544, createdName=zqz520, createdTime=Tue Jun 28 15:57:00 CST 2011, time=2011-06-28, status=1, ipAttribution=)]
    2021-02-21 病理微人

    审稿速度:2.0 | 投稿命中率:95.0
    经验分享：去年疫情期间投稿两篇文章，审稿时间回复很快，1-1.5月，一篇按照专家意见反复修改，另一篇小修。应该是心血管病理专业文章，对口强，均已经发表。

    2

    展开2条回复
  2. [GetPortalCommentsPageByObjectIdResponse(id=926075, encodeId=1cb79260e563, content=审稿速度:2.0 | 投稿命中率:95.0<br>经验分享：去年疫情期间投稿两篇文章，审稿时间回复很快，1-1.5月，一篇按照专家意见反复修改，另一篇小修。应该是心血管病理专业文章，对口强，均已经发表。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=143, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=176b1539528, createdName=病理微人, createdTime=Sun Feb 21 11:32:00 CST 2021, time=2021-02-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=509710, encodeId=74eb509e10cd, content=审稿速度:3.0 | 投稿命中率:50.0<br>经验分享：本人投了一篇综述，中了，有关先天性心脏病分子机制的，在当时比较有创意，小修后就收了。感觉不是很难。后来投了一篇论著，直接被拒了。Huang JB, Liu YL, Sun PW, Lv XD, Du M, Fan XM. Molecular mechanisms of congenital heart disease.Cardiovasc Pathol. 2010 Sep-Oct;19(5):e183-93., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=430, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=85f118338, createdName=b2007117, createdTime=Mon Feb 09 16:42:00 CST 2015, time=2015-02-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=849465, encodeId=8497849465d4, content=相对不错的一个期刊，这几年if慢慢起来了，应该可以吸引到更多好文章吧 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=146, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a87f5414135, createdName=ms9016875260525266, createdTime=Wed Jan 23 17:29:33 CST 2019, time=2019-01-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=539957, encodeId=b4b453995e8a, content=有所上涨，看好未来，大家认为呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=350, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=yang_guoqiang2010, createdTime=Tue Jul 18 18:37:00 CST 2017, time=2017-07-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=491322, encodeId=fa404913227f, content=审稿速度:1.0 | 投稿命中率:25.0<br>经验分享：三篇都是大修，然后都被拒, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=400, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=Dong, createdTime=Fri Nov 02 10:43:00 CST 2012, time=2012-11-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=478307, encodeId=e6664e830766, content=偏重的研究方向：心血管;, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=430, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=null, createdTime=Wed Jun 29 15:29:00 CST 2011, time=2011-06-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=477150, encodeId=a9cd4e71505b, content=偏重的研究方向：心血管;, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=536, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6d5828544, createdName=zqz520, createdTime=Tue Jun 28 15:57:00 CST 2011, time=2011-06-28, status=1, ipAttribution=)]
    2015-02-09 b2007117

    审稿速度:3.0 | 投稿命中率:50.0
    经验分享：本人投了一篇综述，中了，有关先天性心脏病分子机制的，在当时比较有创意，小修后就收了。感觉不是很难。后来投了一篇论著，直接被拒了。Huang JB, Liu YL, Sun PW, Lv XD, Du M, Fan XM. Molecular mechanisms of congenital heart disease.Cardiovasc Pathol. 2010 Sep-Oct;19(5):e183-93.

    1

    展开1条回复
  3. [GetPortalCommentsPageByObjectIdResponse(id=926075, encodeId=1cb79260e563, content=审稿速度:2.0 | 投稿命中率:95.0<br>经验分享：去年疫情期间投稿两篇文章，审稿时间回复很快，1-1.5月，一篇按照专家意见反复修改，另一篇小修。应该是心血管病理专业文章，对口强，均已经发表。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=143, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=176b1539528, createdName=病理微人, createdTime=Sun Feb 21 11:32:00 CST 2021, time=2021-02-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=509710, encodeId=74eb509e10cd, content=审稿速度:3.0 | 投稿命中率:50.0<br>经验分享：本人投了一篇综述，中了，有关先天性心脏病分子机制的，在当时比较有创意，小修后就收了。感觉不是很难。后来投了一篇论著，直接被拒了。Huang JB, Liu YL, Sun PW, Lv XD, Du M, Fan XM. Molecular mechanisms of congenital heart disease.Cardiovasc Pathol. 2010 Sep-Oct;19(5):e183-93., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=430, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=85f118338, createdName=b2007117, createdTime=Mon Feb 09 16:42:00 CST 2015, time=2015-02-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=849465, encodeId=8497849465d4, content=相对不错的一个期刊，这几年if慢慢起来了，应该可以吸引到更多好文章吧 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=146, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a87f5414135, createdName=ms9016875260525266, createdTime=Wed Jan 23 17:29:33 CST 2019, time=2019-01-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=539957, encodeId=b4b453995e8a, content=有所上涨，看好未来，大家认为呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=350, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=yang_guoqiang2010, createdTime=Tue Jul 18 18:37:00 CST 2017, time=2017-07-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=491322, encodeId=fa404913227f, content=审稿速度:1.0 | 投稿命中率:25.0<br>经验分享：三篇都是大修，然后都被拒, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=400, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=Dong, createdTime=Fri Nov 02 10:43:00 CST 2012, time=2012-11-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=478307, encodeId=e6664e830766, content=偏重的研究方向：心血管;, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=430, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=null, createdTime=Wed Jun 29 15:29:00 CST 2011, time=2011-06-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=477150, encodeId=a9cd4e71505b, content=偏重的研究方向：心血管;, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=536, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6d5828544, createdName=zqz520, createdTime=Tue Jun 28 15:57:00 CST 2011, time=2011-06-28, status=1, ipAttribution=)]
    2019-01-23 ms9016875260525266

    相对不错的一个期刊，这几年if慢慢起来了，应该可以吸引到更多好文章吧

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=926075, encodeId=1cb79260e563, content=审稿速度:2.0 | 投稿命中率:95.0<br>经验分享：去年疫情期间投稿两篇文章，审稿时间回复很快，1-1.5月，一篇按照专家意见反复修改，另一篇小修。应该是心血管病理专业文章，对口强，均已经发表。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=143, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=176b1539528, createdName=病理微人, createdTime=Sun Feb 21 11:32:00 CST 2021, time=2021-02-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=509710, encodeId=74eb509e10cd, content=审稿速度:3.0 | 投稿命中率:50.0<br>经验分享：本人投了一篇综述，中了，有关先天性心脏病分子机制的，在当时比较有创意，小修后就收了。感觉不是很难。后来投了一篇论著，直接被拒了。Huang JB, Liu YL, Sun PW, Lv XD, Du M, Fan XM. Molecular mechanisms of congenital heart disease.Cardiovasc Pathol. 2010 Sep-Oct;19(5):e183-93., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=430, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=85f118338, createdName=b2007117, createdTime=Mon Feb 09 16:42:00 CST 2015, time=2015-02-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=849465, encodeId=8497849465d4, content=相对不错的一个期刊，这几年if慢慢起来了，应该可以吸引到更多好文章吧 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=146, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a87f5414135, createdName=ms9016875260525266, createdTime=Wed Jan 23 17:29:33 CST 2019, time=2019-01-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=539957, encodeId=b4b453995e8a, content=有所上涨，看好未来，大家认为呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=350, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=yang_guoqiang2010, createdTime=Tue Jul 18 18:37:00 CST 2017, time=2017-07-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=491322, encodeId=fa404913227f, content=审稿速度:1.0 | 投稿命中率:25.0<br>经验分享：三篇都是大修，然后都被拒, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=400, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=Dong, createdTime=Fri Nov 02 10:43:00 CST 2012, time=2012-11-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=478307, encodeId=e6664e830766, content=偏重的研究方向：心血管;, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=430, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=null, createdTime=Wed Jun 29 15:29:00 CST 2011, time=2011-06-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=477150, encodeId=a9cd4e71505b, content=偏重的研究方向：心血管;, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=536, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6d5828544, createdName=zqz520, createdTime=Tue Jun 28 15:57:00 CST 2011, time=2011-06-28, status=1, ipAttribution=)]
    2017-07-18 yang_guoqiang2010

    有所上涨，看好未来，大家认为呢？

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=926075, encodeId=1cb79260e563, content=审稿速度:2.0 | 投稿命中率:95.0<br>经验分享：去年疫情期间投稿两篇文章，审稿时间回复很快，1-1.5月，一篇按照专家意见反复修改，另一篇小修。应该是心血管病理专业文章，对口强，均已经发表。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=143, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=176b1539528, createdName=病理微人, createdTime=Sun Feb 21 11:32:00 CST 2021, time=2021-02-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=509710, encodeId=74eb509e10cd, content=审稿速度:3.0 | 投稿命中率:50.0<br>经验分享：本人投了一篇综述，中了，有关先天性心脏病分子机制的，在当时比较有创意，小修后就收了。感觉不是很难。后来投了一篇论著，直接被拒了。Huang JB, Liu YL, Sun PW, Lv XD, Du M, Fan XM. Molecular mechanisms of congenital heart disease.Cardiovasc Pathol. 2010 Sep-Oct;19(5):e183-93., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=430, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=85f118338, createdName=b2007117, createdTime=Mon Feb 09 16:42:00 CST 2015, time=2015-02-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=849465, encodeId=8497849465d4, content=相对不错的一个期刊，这几年if慢慢起来了，应该可以吸引到更多好文章吧 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=146, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a87f5414135, createdName=ms9016875260525266, createdTime=Wed Jan 23 17:29:33 CST 2019, time=2019-01-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=539957, encodeId=b4b453995e8a, content=有所上涨，看好未来，大家认为呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=350, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=yang_guoqiang2010, createdTime=Tue Jul 18 18:37:00 CST 2017, time=2017-07-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=491322, encodeId=fa404913227f, content=审稿速度:1.0 | 投稿命中率:25.0<br>经验分享：三篇都是大修，然后都被拒, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=400, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=Dong, createdTime=Fri Nov 02 10:43:00 CST 2012, time=2012-11-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=478307, encodeId=e6664e830766, content=偏重的研究方向：心血管;, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=430, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=null, createdTime=Wed Jun 29 15:29:00 CST 2011, time=2011-06-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=477150, encodeId=a9cd4e71505b, content=偏重的研究方向：心血管;, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=536, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6d5828544, createdName=zqz520, createdTime=Tue Jun 28 15:57:00 CST 2011, time=2011-06-28, status=1, ipAttribution=)]
    2012-11-02 Dong

    审稿速度:1.0 | 投稿命中率:25.0
    经验分享：三篇都是大修，然后都被拒

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=926075, encodeId=1cb79260e563, content=审稿速度:2.0 | 投稿命中率:95.0<br>经验分享：去年疫情期间投稿两篇文章，审稿时间回复很快，1-1.5月，一篇按照专家意见反复修改，另一篇小修。应该是心血管病理专业文章，对口强，均已经发表。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=143, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=176b1539528, createdName=病理微人, createdTime=Sun Feb 21 11:32:00 CST 2021, time=2021-02-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=509710, encodeId=74eb509e10cd, content=审稿速度:3.0 | 投稿命中率:50.0<br>经验分享：本人投了一篇综述，中了，有关先天性心脏病分子机制的，在当时比较有创意，小修后就收了。感觉不是很难。后来投了一篇论著，直接被拒了。Huang JB, Liu YL, Sun PW, Lv XD, Du M, Fan XM. Molecular mechanisms of congenital heart disease.Cardiovasc Pathol. 2010 Sep-Oct;19(5):e183-93., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=430, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=85f118338, createdName=b2007117, createdTime=Mon Feb 09 16:42:00 CST 2015, time=2015-02-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=849465, encodeId=8497849465d4, content=相对不错的一个期刊，这几年if慢慢起来了，应该可以吸引到更多好文章吧 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=146, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a87f5414135, createdName=ms9016875260525266, createdTime=Wed Jan 23 17:29:33 CST 2019, time=2019-01-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=539957, encodeId=b4b453995e8a, content=有所上涨，看好未来，大家认为呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=350, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=yang_guoqiang2010, createdTime=Tue Jul 18 18:37:00 CST 2017, time=2017-07-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=491322, encodeId=fa404913227f, content=审稿速度:1.0 | 投稿命中率:25.0<br>经验分享：三篇都是大修，然后都被拒, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=400, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=Dong, createdTime=Fri Nov 02 10:43:00 CST 2012, time=2012-11-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=478307, encodeId=e6664e830766, content=偏重的研究方向：心血管;, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=430, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=null, createdTime=Wed Jun 29 15:29:00 CST 2011, time=2011-06-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=477150, encodeId=a9cd4e71505b, content=偏重的研究方向：心血管;, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=536, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6d5828544, createdName=zqz520, createdTime=Tue Jun 28 15:57:00 CST 2011, time=2011-06-28, status=1, ipAttribution=)]
    2011-06-29 匿名用户

    偏重的研究方向：心血管;

    0

  7. [GetPortalCommentsPageByObjectIdResponse(id=926075, encodeId=1cb79260e563, content=审稿速度:2.0 | 投稿命中率:95.0<br>经验分享：去年疫情期间投稿两篇文章，审稿时间回复很快，1-1.5月，一篇按照专家意见反复修改，另一篇小修。应该是心血管病理专业文章，对口强，均已经发表。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=143, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=176b1539528, createdName=病理微人, createdTime=Sun Feb 21 11:32:00 CST 2021, time=2021-02-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=509710, encodeId=74eb509e10cd, content=审稿速度:3.0 | 投稿命中率:50.0<br>经验分享：本人投了一篇综述，中了，有关先天性心脏病分子机制的，在当时比较有创意，小修后就收了。感觉不是很难。后来投了一篇论著，直接被拒了。Huang JB, Liu YL, Sun PW, Lv XD, Du M, Fan XM. Molecular mechanisms of congenital heart disease.Cardiovasc Pathol. 2010 Sep-Oct;19(5):e183-93., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=430, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=85f118338, createdName=b2007117, createdTime=Mon Feb 09 16:42:00 CST 2015, time=2015-02-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=849465, encodeId=8497849465d4, content=相对不错的一个期刊，这几年if慢慢起来了，应该可以吸引到更多好文章吧 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=146, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a87f5414135, createdName=ms9016875260525266, createdTime=Wed Jan 23 17:29:33 CST 2019, time=2019-01-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=539957, encodeId=b4b453995e8a, content=有所上涨，看好未来，大家认为呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=350, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=yang_guoqiang2010, createdTime=Tue Jul 18 18:37:00 CST 2017, time=2017-07-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=491322, encodeId=fa404913227f, content=审稿速度:1.0 | 投稿命中率:25.0<br>经验分享：三篇都是大修，然后都被拒, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=400, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=Dong, createdTime=Fri Nov 02 10:43:00 CST 2012, time=2012-11-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=478307, encodeId=e6664e830766, content=偏重的研究方向：心血管;, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=430, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=null, createdTime=Wed Jun 29 15:29:00 CST 2011, time=2011-06-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=477150, encodeId=a9cd4e71505b, content=偏重的研究方向：心血管;, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=536, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6d5828544, createdName=zqz520, createdTime=Tue Jun 28 15:57:00 CST 2011, time=2011-06-28, status=1, ipAttribution=)]
    2011-06-28 zqz520

    偏重的研究方向：心血管;

    0

共10条页码: 1/1页10条/页
分享您的投稿经验，提升MI经验值，获取更多积分

Baidu
Baidu
map
Baidu
map
Baidu
map